Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma

Journal of Proteome Research

Volumn 7, Issue 11, 2008, Pages 4670-4677

  Kristiansen, Troels Zakarias ^a,b   Harsha, H C ^a,c,d   Grønborg, Mads ^a,b   Maitra, Anirban ^a   Pandey, Akhilesh ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Institute of Bioinformatics   (India)

^d MANIPAL UNIVERSITY   (India)

Author keywords

18O stable isotope labeling; Gall bladder; Immunohistochemistry; Liquid chromatography tandem mass spectrometry (LC MS MS); Quantitative proteomics; Tissue microarrays

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LIPOCORTIN 4; MEMBRANE PROTEIN; OXYGEN 18; OXYGEN; PROTEOME; TUMOR MARKER;

ARTICLE; BILE DUCT CARCINOMA; CONTROLLED STUDY; GOLGI COMPLEX; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; TISSUE MICROARRAY; BILE DUCT TUMOR; CASE CONTROL STUDY; CELL STRUCTURE; CHEMISTRY; GENETICS; INTRAHEPATIC BILE DUCT; MEMBRANE; METHODOLOGY; MICROARRAY ANALYSIS; PATHOLOGY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CASE-CONTROL STUDIES; CELLULAR STRUCTURES; CHOLANGIOCARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; MEMBRANES; MICROARRAY ANALYSIS; OXYGEN ISOTOPES; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 58149382052     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800215n     Document Type: Article

References (35)

1. Khan, S. A.; Taylor-Robinson, S. D.; Toledano, M. B.; Beck, A.; Elliott, P.; Thomas, H. C. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J. Hepatol. 2002, 37, 806-813.
2. Khan, S. A.; Thomas, H. C; Davidson, B. R.; Taylor-Robinson, S. D. Cholangiocarcinoma. Lancet 2005, 366, 1303-1314.
3. de Groen, P. C; Gores, G. J.; LaRusso, N. F.; Gunderson, L. L.; Nagorney, D. M. Biliary tract cancers. N. Engl. J. Med. 1999, 341, 1368-1378.
4. Gores, G. J. Early detection and treatment of cholangiocarcinoma. Liver Transpl. 2000, 6, S30-34.
5. Bjornsson, E.; Kilander, A.; Olsson, R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 1999, 19, 501-508.
6. Patel, A. H.; Harnois, D. M.; Hee, G. G.; LaRusso, N. F.; Gores, G. J. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am. J. Gastroenterol. 2000, 95, 204-207.
7. Rubio-Viqueira, B.; Jimeno, A.; Cusatis, G.; Zhang, X.; Iacobuzio-Donahue, C; Karikari, C; Shi, C; Danenberg, K.; Danenberg, P. V.; Kuramochi, H.; Tanaka, K.; Singh, S.; Salimi-Moosavi, H.; Bouraoud, N.; Amador, M. L.; Altiok, S.; Kulesza, P.; Yeo, C; Messersmith, W.; Eshleman, J.; Hruban, R. H.; Maitra, A.; Hidalgo, M. An in vivo platform for translational drug development in pancreatic cancer. Clin. Cancer Res. 2006, 12, 4652-4661.
8. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
9. Swierczynski, S. L.; Maitra, A.; Abraham, S. C; Iacobuzio-Donahue, C. A.; Ashfaq, R.; Cameron, J. L.; Schulick, R. D.; Yeo, C. J.; Rahman, A.; Hinkle, D. A.; Hruban, R. H.; Argani, P. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue mi-croarrays. Hum. Pathol. 2004, 35, 357-366.
10. Hustinx, S. R.; Hruban, R. H.; Leoni, L. M.; Iacobuzio-Donahue, C; Cameron, J. L.; Yeo, C. J.; Brown, P. N.; Argani, P.; Ashfaq, R.; Fukushima, N.; Goggins, M.; Kern, S. E.; Maitra, A. Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy. Cancer Biol. Ther. 2005, 4, 83-86.
11. Russ, A. P.; Lampel, S. The druggable genome: an update. Drug Discovery Today 2005, 10, 1607-1610.
12. Hopkins, A. L.; Groom, C. R. The druggable genome. Nat. Rev. Drug Discovery 2002, 1, 727-730.
13. Fujiki, Y.; Hubbard, A. L.; Fowler, S.; Lazarow, P. B. Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J. Cell Biol. 1982, 93, 97-102.
14. 16O quantitative pro-teomics experiments by incorporation of immobilized trypsin into the initial digestion step. Anal. Chem. 2007, 79, 2158-2162.
15. Ghosh, M.; Kamma, H.; Kawamoto, T.; Koike, N.; Miwa, M.; Kapoor, V. K.; Krishnani, N.; Agrawal, S.; Ohkohchi, N.; Todoroki, T. MUC 1 core protein as a marker of gallbladder malignancy. Eur. J. Surg. Oncol. 2005, 31, 891-896.
16. Sasaki, M.; Nakanuma, Y. Abnormal expression of MUC1 apomucin and mature MUC1 mucin in biliary epithelial cells in various cystic liver diseases. Hepatology 1996, 24, 539-543.
17. Sasaki, M.; Nakanuma, Y. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohis-tochemical study. Hepatology 1996, 23, 1313-1317.
18. Takagawa, M.; Muguruma, N.; Oguri, K.; Imoto, Y.; Okamoto, K.; Ii, K.; Ito, S. Prediction of prognosis in gallbladder carcinoma by mucin and p53 immunohistochemistry. Dig. Dis. Sci. 2005, 50, 1410-1413.
19. Sasaki, M.; Nakanuma, Y.; Kim, Y. S. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. Hepatology 1996, 24, 1074-1078.
20. Iftikhar, R.; Kladney, R. D.; Havlioglu, N.; Schmitt-Graff, A.; Gusmirovic, I.; Solomon, H.; Luxon, B. A.; Bacon, B. R.; Fimmel, C. J. Disease-and cell-specific expression of GP73 in human liver disease. Am. J. Gastroenterol. 2004, 99, 1087-1095.
21. Block, T. M.; Comunale, M. A.; Lowman, M.; Steel, L. F.; Romano, P. R.; Fimmel, C; Tennant, B. C; London, W. T.; Evans, A. A.; Blumberg, B. S.; Dwek, R. A.; Mattu, T. S.; Mehta, A. S. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. U.S.A 2005, 102, 779-784.
22. Schwegler, E. E.; Cazares, L.; Steel, L. F.; Adam, B. L.; Johnson, D. A.; Semmes, O. J.; Block, T. M.; Marrero, J. A.; Drake, R. R. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology 2005, 41, 634-642.
23. Marrero, J. A.; Romano, P. R.; Nikolaeva, O.; Steel, L.; Mehta, A.; Fimmel, C. J.; Comunale, M. A.; D'Amelio, A.; Lok, A. S.; Block, T. M. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J. Hepatol. 2005, 43, 1007-1012.
24. Grundmann, U.; Amann, E.; Abel, K. J.; Kupper, H. A. Isolation and expression of cDNA coding for a new member of the phospholipase A2 inhibitor family. Behring Inst. Mitt. 1988, 59-67.
25. Hauptmann, R.; Maurer-Fogy, I.; Krystek, E.; Bodo, G.; ree, H.; Reutelingsperger, C. P. Vascular anticoagulant beta: a novel human Ca2+/phospholipid binding protein that inhibits coagulation and phospholipase A2 activity. Its molecular cloning, expression and comparison with VAC-alpha. Eur. J. Biochem. 1989, 185, 63-71.
26. Piljic, A.; Schultz, C. Annexin A4 self-association modulates general membrane protein mobility in living cells. Mol. Biol Cell 2006, 17, 3318-3328.
27. Zimmermann, U.; Balabanov, S.; Giebel, J.; Teller, S.; Junker, H.; Schmoll, D.; Protzel, C; Scharf, C.; Meist, B.; Walther, R. Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett 2004, 209, 111-118.
28. Di Fiore, P. P.; Scita, G. Eps8 in the midst of GTPases. Int. J. Biochem. Cell Biol. 2002, 34, 1178-1183.
29. Funato, Y.; Terabayashi, T.; Suenaga, N.; Seiki, M.; Takenawa, T.; Miki, H. IRSp53/Eps8 complex is important for positive regulation of Rac and cancer cell motility/invasiveness. Cancer Res. 2004, 64, 5237-5244.
30. Barry, W. T.; Boudignon-Proudhon, C.; Shock, D. D.; McFadden, A.; Weiss, J. M.; Sondek, J.; Parise, L. V. Molecular basis of CIB binding to the integrin alpha IIb cytoplasmic domain. J. Biol. Chem. 2002, 277, 28877-28883.
31. Naik, U. P.; Naik, M. U. Association of CIB with GPIIb/IIIa during outside-in signaling is required for platelet spreading on fibrinogen. Blood 2003, 102, 1355-1362.
32. Naik, M. U.; Naik, U. P. Calcium-and integrin-binding protein regulates focal adhesion kinase activity during platelet spreading on immobilized fibrinogen. Blood 2003, 102, 3629-3636.
33. Haataja, L.; Kaartinen, V.; Groffen, J.; Heisterkamp, N. The small GTPase Rac3 interacts with the integrin-binding protein CIB and promotes integrin alpha(Hb)beta(3)-mediated adhesion and spreading. J. Biol. Chem. 2002, 277, 8321-8328.
34. Bernstein, H. G.; Blazejczyk, M.; Rudka, T.; Gundelfinger, E. D.; Dobrowolny, H.; Bogerts, B.; Kreutz, M. R.; Kuznicki, J.; Wojda, U. The Alzheimer disease-related calcium-binding protein Calmyrin is present in human forebrain with an altered distribution in Alzheimer's as compared to normal ageing brains. Neuropathol. Appl. Neurobiol 2005, 31, 314-324.
35. DeSouza, L.; Diehl, G.; Rodrigues, M. J.; Guo, J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 2005, 4, 377-386.